Stephen E. Mercer

Person

Greenville, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Naphthyridinone compounds useful as T cell activators
- Patent number 11,866,430
- Issue date Jan 9, 2024
- Bristol-Myers Squibb Company
- Louis S. Chupak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of selecting therapeutic molecules
- Patent number 11,761,951
- Issue date Sep 19, 2023
- Bristol-Myers Squibb Company
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tau antisense oligomers and uses thereof
- Patent number 11,077,132
- Issue date Aug 3, 2021
- F. Hoffmann-La Roche AG
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CAMK2D antisense oligonucleotides and uses thereof
- Patent number 11,058,767
- Issue date Jul 13, 2021
- Bristol-Myers Squibb Company
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tau antisense oligomers and uses thereof
- Patent number 10,799,523
- Issue date Oct 13, 2020
- F. Hoffmann-La Roche AG
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Difluoromethoxy compound with low bioactivation potential for the r...
- Patent number 9,833,454
- Issue date Dec 5, 2017
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic agents for the treatment of migraine
- Patent number 7,772,244
- Issue date Aug 10, 2010
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constrained compounds as CGRP-receptor antagonists
- Patent number 7,544,680
- Issue date Jun 9, 2009
- Bristol-Myers Squibb Company
- Prasad V. Chaturvedula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constrained compounds as CGRP-receptor antagonists
- Patent number 7,470,680
- Issue date Dec 30, 2008
- Bristol-Myers Squibb Company
- Prasad V. Chaturvedula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constrained compounds as CGRP-receptor antagonists
- Patent number 7,470,679
- Issue date Dec 30, 2008
- Bristol-Myers Squibb Company
- Stephen E. Mercer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constrained compounds as CGRP-receptor antagonists
- Patent number 7,384,931
- Issue date Jun 10, 2008
- Bristol-Myers Squibb Company
- Prasad V. Chaturvedula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constrained compounds as CGRP-receptor antagonists
- Patent number 7,384,930
- Issue date Jun 10, 2008
- Bristol-Myers Squibb Company
- Prasad V. Chaturvedula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazoline derivatives as inhibitors of matrix metalloproteinases...
- Patent number 7,125,870
- Issue date Oct 24, 2006
- Bristol-Myers Squibb Company
- Chu-Biao Xue
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lactam metalloprotease inhibitors
- Patent number 6,620,823
- Issue date Sep 16, 2003
- Bristol-Myers Squibb Pharme Company
- Thomas P Maduskuie
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
- Publication number 20220213484
- Publication date Jul 7, 2022
- Bristol-Myers Squibb Company
- Brian R. ANDERSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TAU ANTISENSE OLIGOMERS AND USES THEREOF
- Publication number 20220143064
- Publication date May 12, 2022
- F. Hoffmann-La Roche AG
- Richard E. Olson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
- Publication number 20210378652
- Publication date Dec 9, 2021
- Bristol-Myers Squibb Company
- Richard E. OLSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210277004
- Publication date Sep 9, 2021
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Selecting Therapeutic Molecules
- Publication number 20190383797
- Publication date Dec 19, 2019
- Bristol-Myers Squibb Company
- Richard E. OLSON
- G01 - MEASURING TESTING
Information Patent Application
CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF
- Publication number 20190275148
- Publication date Sep 12, 2019
- Bristol-Myers Squibb Company
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TAU ANTISENSE OLIGOMERS AND USES THEREOF
- Publication number 20180161356
- Publication date Jun 14, 2018
- Richard E. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIFLUOROMETHOXY COMPOUND WITH LOW BIOACTIVATION POTENTIAL FOR THE R...
- Publication number 20170182050
- Publication date Jun 29, 2017
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tau Antisense Oligomers and Uses Thereof
- Publication number 20160237427
- Publication date Aug 18, 2016
- Bristol-Myers Squibb Company
- Richard E. OLSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Constrained Compounds as CGRP-Receptor Antagonists
- Publication number 20080287422
- Publication date Nov 20, 2008
- Bristol -Myers Squibb Company
- Prasad V. Chaturvedula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS
- Publication number 20070259850
- Publication date Nov 8, 2007
- Bristol -Myers Squibb Company
- Stephen E. Mercer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS
- Publication number 20070259851
- Publication date Nov 8, 2007
- Bristol -Myers Squibb Company
- Prasad V. Chaturvedula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Constrained compounds as CGRP-receptor antagonists
- Publication number 20060229447
- Publication date Oct 12, 2006
- Prasad V. Chaturvedula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Constrained compounds as CGRP-receptor antagonists
- Publication number 20060094707
- Publication date May 4, 2006
- Prasad V. Chaturvedula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel therapeutic agents for the treatment of migraine
- Publication number 20050215576
- Publication date Sep 29, 2005
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazoline derivatives as inhibitors of matrix metalloproteinases...
- Publication number 20040122005
- Publication date Jun 24, 2004
- Chu-Biao Xue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel lactam metalloprotease inhibitors
- Publication number 20020042398
- Publication date Apr 11, 2002
- Thomas P. Maduskuie
- C07 - ORGANIC CHEMISTRY

Stephen E. Mercer

Person

Patents Grantslast 30 patents

Naphthyridinone compounds useful as T cell activators

Methods of selecting therapeutic molecules

Tau antisense oligomers and uses thereof

CAMK2D antisense oligonucleotides and uses thereof

Tau antisense oligomers and uses thereof

Difluoromethoxy compound with low bioactivation potential for the r...

Therapeutic agents for the treatment of migraine

Constrained compounds as CGRP-receptor antagonists

Constrained compounds as CGRP-receptor antagonists

Constrained compounds as CGRP-receptor antagonists

Constrained compounds as CGRP-receptor antagonists

Constrained compounds as CGRP-receptor antagonists

Isoxazoline derivatives as inhibitors of matrix metalloproteinases...

Lactam metalloprotease inhibitors

Patents Applicationslast 30 patents

ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

TAU ANTISENSE OLIGOMERS AND USES THEREOF

CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

Methods of Selecting Therapeutic Molecules

CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

TAU ANTISENSE OLIGOMERS AND USES THEREOF

DIFLUOROMETHOXY COMPOUND WITH LOW BIOACTIVATION POTENTIAL FOR THE R...

Tau Antisense Oligomers and Uses Thereof

Constrained Compounds as CGRP-Receptor Antagonists

CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS

CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS

Constrained compounds as CGRP-receptor antagonists

Constrained compounds as CGRP-receptor antagonists

Novel therapeutic agents for the treatment of migraine

Isoxazoline derivatives as inhibitors of matrix metalloproteinases...

Novel lactam metalloprotease inhibitors